AC
IDYA icon

AlphaCore Capital’s IDEAYA Biosciences IDYA Stock Holding History

AlphaCore Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
57,077
-329
-0.6% -$10.1K 0.04% 299
2026
Q1 		$1.91M Buy
57,406
+50,649
+750% +$1.7M 0.05% 259
2025
Q4 		$234K Buy
+6,757
New +$215K 0.01% 917

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AlphaCore Capital's IDYA Position: Q2 2026 in Review

AlphaCore Capital reduced its IDEAYA Biosciences (IDYA) stake by 0.57% in Q2 2026, selling an estimated $10.1K and leaving 57,077 shares worth $2.13M. The position accounts for 0.04% of the portfolio, ranked #299.

AlphaCore Capital first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • AlphaCore Capital held 57,077 shares of IDEAYA Biosciences worth $2.13M as of Q2 2026.
  • AlphaCore Capital sold 329 IDEAYA Biosciences shares in Q2 2026, an estimated $10.1K.
  • IDEAYA Biosciences made up 0.04% of AlphaCore Capital's portfolio in Q2 2026, its #299 holding.
  • AlphaCore Capital first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.